Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes.

Autor: Zhand N; Schizophrenia and Recovery Program, The Royal Ottawa Mental Health Centre, Canada.; University of Ottawa, Department of Psychiatry, Canada., Attwood D; Schizophrenia and Recovery Program, The Royal Ottawa Mental Health Centre, Canada.; University of Ottawa, Department of Psychiatry, Canada., Labelle A; Schizophrenia and Recovery Program, The Royal Ottawa Mental Health Centre, Canada.; University of Ottawa, Department of Psychiatry, Canada., Joober R; McGill University, Department of Psychiatry, Canada.; Douglas Mental Health University Institute, Canada., Robertson C; Schizophrenia and Recovery Program, The Royal Ottawa Mental Health Centre, Canada., Harvey PD; University of Miami Miller School of Medicine, Miami, FL, United States.

Publikováno v: Contemporary clinical trials communications [Contemp Clin Trials Commun] 2024 Jul 25; Vol. 41, pp. 101337. Date of Electronic Publication: 2024 Jul 25 (Print Publication: 2024).

Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review.

Autor: Arsenault-Mehta K; The Royal Ottawa Mental Health Center, The University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., Hochman-Bérard M; The University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., Johnson A; The University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., Semenova D; The University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., Nguyen B; The University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., Willis J; The University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., Mouravska N; The Royal Ottawa Mental Health Center, The University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada., Joober R; Department of Psychiatry, McGill University, Montreal, Quebec, Canada., Zhand N; The Royal Ottawa Mental Health Center, The University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.

Publikováno v: Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Mar; Vol. 44 (1), pp. 2-16. Date of Electronic Publication: 2023 Oct 04.

The prevalence of abdominal aortic aneurysm in Iranian male population over 65 years old

Autor: Mirsharifi R, Zhand N, Shahriyarian Sh, Meysamie A, Mirsharifi A, Aminian A

Publikováno v: Tehran University Medical Journal, Vol 69, Iss 5, Pp 322-326 (2011)

"nBackground: Prevalence of Abdominal Aortic Aneurysm (AAA), estimated by various studies, ranged from 4.1% to 14.2% in men older than 60 years. Most cases of AAA are asymptomatic and often discovered incidentally. Approximately the initial presentat

Externí odkaz: https://doaj.org/article/bb499bc059404333b789c6ee9410860e

Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics.

Autor: Zhand N, Labelle A, Ghanem D; Department of Psychiatry, University of Ottawa, Ottawa, Canada., Gujral P; Department of Psychiatry, University of Ottawa, Ottawa, Canada., Han T; Department of Psychiatry, University of Ottawa, Ottawa, Canada., Huneault G; Department of Psychiatry, University of Ottawa, Ottawa, Canada., Jain GK; Department of Psychiatry, University of Ottawa, Ottawa, Canada., Robertson C; From the Schizophrenia Recovery Program, The Royal Ottawa Mental Health Centre.

Publikováno v: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2022 Sep-Oct 01; Vol. 42 (5), pp. 475-479. Date of Electronic Publication: 2022 Aug 18.

Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation.

Autor: Labonté C; The Royal Ottawa Mental Health Center, Schizophrenia and Recovery Program, 1145 Carling Ave, Ottawa, Ontario K1Z 7K4, Canada; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Zhand N; The Royal Ottawa Mental Health Center, Schizophrenia and Recovery Program, 1145 Carling Ave, Ottawa, Ontario K1Z 7K4, Canada; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: Naista.Zhand@theroyal.ca., Park A; The Royal Ottawa Mental Health Center, Schizophrenia and Recovery Program, 1145 Carling Ave, Ottawa, Ontario K1Z 7K4, Canada., Harvey PD; University of Miami Miller School of Medicine, Miami, FL, United States.

Publikováno v: Psychiatry research [Psychiatry Res] 2022 Feb; Vol. 308, pp. 114382. Date of Electronic Publication: 2021 Dec 31.